Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
Completed
Conditions studied: Relapsing Forms of Multiple Sclerosis
In brief
The primary objective of the study is to estimate the annualized relapse rate (ARR) over a 12-month period in patients with relapsing forms of multiple sclerosis (MS) who are treated with dimethyl fumarate (DMF) after suboptimal response to glatiramer acetate (GA). The secondary objectives of this study in this study population are to assess the impact of DMF over a 12-month period on patient-reported outcomes (PROs) and health economic-related outcomes and to evaluate additional clinical outcomes at Month 12.
Key facts
- Study ID
- NCT01903291
- Run by
- Biogen
- People needed
- 333
- Starts
- 2013-08-01
- Expected to finish
- 2016-02-01
- Last updated by the study team
- 2016-07-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Tuscon, Arizona, United States
- Research Site — Los Angeles, California, United States
- Research Site — Sacramento, California, United States
- Research Site — San Jose, California, United States
- Research Site — Englewood, Colorado, United States
- Research Site — Dover, Delaware, United States
- Research Site — Jacksonville, Florida, United States
- Research Site — Lighthouse PT, Florida, United States
- Research Site — Port Charlotte, Florida, United States
- Research Site — St. Petersburg, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Savannah, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Evanston, Illinois, United States
- Research Site — Franklin, Illinois, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Des Moines, Iowa, United States
- Research Site — Lenexa, Kansas, United States
- Research Site — Lexington, Kentucky, United States
- Research Site — Louisville, Kentucky, United States
- Research Site — Baton Rouge, Louisiana, United States
- Research Site — Annapolis, Maryland, United States
- Research Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.